Home / 2185.HK / Financial Statements

Shanghai Bioheart Biological Technology Co Ltd (2185.HK)

Healthcare | Biotechnology
Income Statement (Quarterly) 2026-04-07 2025-06-30 2025-03-31 2024-12-31
Revenue 20,862,000 20,862,000 10,431,000 0
Cost of Revenue 11,167,000 11,167,000 5,583,500 0
Gross Profit 9,695,000 9,695,000 4,847,500 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 10,837,000 10,837,000 5,418,500 6,328,000
Operating Expenses 30,927,000 30,927,000 15,463,500 16,082,500
Operating Income -21,232,000 -21,232,000 -10,616,000 -16,082,500
Interest Expense 0 2,728,000 0 0
Income Before Tax -27,420,000 -27,420,000 -13,710,000 -32,499,499
Income Tax Expense 686,000 686,000 343,000 0
Net Income -27,213,000 -27,213,000 -13,606,500 -31,057,000
Per Share
EPS -0.11 -0.11 -0.06 -0.13
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31
Revenue 0 0
Cost of Revenue 0 23,597,232
Gross Profit 0 -23,597,232
Operating Expenses
R&D Expenses 0 0
SG&A Expenses 19,740,000 49,343,685
Operating Expenses 61,040,000 163,676,000
Operating Income -61,040,000 -164,624,000
Interest Expense 0 578,000
Income Before Tax -93,324,000 -188,820,000
Income Tax Expense 0 5,541,412
Net Income -87,944,000 -194,361,412
Per Share
EPS -0.36 -0.80
EPS Diluted 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31
Assets
Cash and Cash Equivalents 202,386,000 369,438,000
Short Term Investments 0 0
Net Receivables 0 0
Inventory 27,583,000 3,980,000
Total Current Assets 299,027,000 408,473,000
Property Plant Equipment 51,578,000 30,906,000
Goodwill and Intangibles 282,217,000 282,340,000
Total Assets 733,776,000 817,899,000
Liabilities
Account Payables 95,000 0
Short Term Debt 1,269,000 1,579,000
Total Current Liabilities 19,649,000 20,069,000
Long Term Debt 7,014,000 183,000
Total Liabilities 53,243,000 44,042,000
Shareholders Equity
Retained Earnings 0 -849,336,000
Total Shareholders Equity 660,468,000 748,412,000
Balance Sheet (Annual) 2024-12-31 2023-12-31
Assets
Cash and Cash Equivalents 202,386,000 369,438,000
Short Term Investments 0 0
Net Receivables 0 0
Inventory 27,583,000 3,980,000
Total Current Assets 299,027,000 408,473,000
Property Plant Equipment 51,578,000 30,906,000
Goodwill and Intangibles 282,217,000 282,340,000
Total Assets 733,776,000 817,899,000
Liabilities
Account Payables 95,000 0
Short Term Debt 1,269,000 1,579,000
Total Current Liabilities 19,649,000 20,069,000
Long Term Debt 7,014,000 183,000
Total Liabilities 53,243,000 44,042,000
Shareholders Equity
Retained Earnings 0 -849,336,000
Total Shareholders Equity 660,468,000 748,412,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31
Operating Activities
Net Income -93,324,000 -188,820,000
Depreciation & Amortization 8,174,000 21,355,000
Stock Based Compensation 0 47,627,000
Change in Working Capital -67,071,000 45,708,000
Operating Cash Flow -119,550,000 -49,028,000
Investing Activities
Capital Expenditure -47,140,000 -17,970,000
Investments -47,140,000 -17,715,000
Investing Cash Flow -46,034,000 -28,856,000
Financing Activities
Debt Repayment 0 0
Common Stock Issued/Repurchased 0 0
Dividends Paid 0 0
Financing Cash Flow -2,442,000 -5,819,000
Summary
Free Cash Flow -166,690,000 -66,998,000
Net Change in Cash -167,052,000 -81,880,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31
Operating Activities
Net Income -93,324,000 -188,820,000
Depreciation & Amortization 8,174,000 21,355,000
Stock Based Compensation 0 47,627,000
Change in Working Capital -67,071,000 45,708,000
Operating Cash Flow -119,550,000 -49,028,000
Investing Activities
Capital Expenditure -47,140,000 -17,970,000
Investments -47,140,000 -17,715,000
Investing Cash Flow -46,034,000 -28,856,000
Financing Activities
Debt Repayment 0 0
Common Stock Issued/Repurchased 0 0
Dividends Paid 0 0
Financing Cash Flow -2,442,000 -5,819,000
Summary
Free Cash Flow -166,690,000 -66,998,000
Net Change in Cash -167,052,000 -81,880,000